No new safety issues found with Roche drugs, EMA says

11/19/2013 | Pharmalot · Reuters

The European Medicines Agency said it has not found any "important new safety concerns” after a yearlong investigation into drugs manufactured by Swiss-based Roche, after the agency found that Roche was not properly assessing reports from physicians about adverse reactions. The EMA also dropped the number of potential negative drug effects from 80,000 to 23,000, according to a Roche representative. The company, which is the world's largest manufacturer of cancer drugs, could still face fines for improper reporting.

View Full Article in:

Pharmalot · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN